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Analysis of the structure of the Y-end of the human ~2(IV) gene demonstrated that the ~l(Ig) and ~2(IV) 
genes have diverged extensively inspite of the apparent homology of the respective gene products. The NC-1 
domain and the Y-untranslated region are encoded by three exons in the ~2(IV) gene but five exons in the 
~l(IV) gene. The two introns present in the NC-1 domain coding part of the ~z(IV) gene had the same loca- 
tion as two of the introns of the ~l(IV) gene. The junction exon in the ~2(IV) gene contains 53 bp coding 
for GIy-X-Y sequences whereas there are 71 bp in the eL(IV ) gene. Three other GIy-X-Y coding exons stud- 
ied from the human ~2(IV) gene have sizes that differ from corresponding exons in the el(IV) gene and only 
one intron location matches here between the two genes. None of the exons studied has 54 bp or multiples 
thereof. 
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1. INTRODUCTION 
The collagen molecules are composed of three ce 
chains which associate to form a triple-helical con- 
formation. The triple-helical region of the c~ chains 
is characterized by Gly-X-Y repeats where X and Y 
frequently represent proline or hydroxyproline [1]. 
To date, at least 12 distinct collagen types have 
been identified. Based on the characteristics of the 
proteins the different collagen types can be divided 
into three groups [1]: group 1 collagens contain 
large ce chains (Mr > 95000) with a continuous 
helix; group 2 collagens have large (Mr > 95000) 
interrupted helices and group 3 collagens contain 
small ce chains with discontinuous helices. Group 1 
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collagens consist of the fibrillar types I - I I I  as well 
as the less characterized types V and XI. Group 2 
contains types IV and V I -V I I I  which do not form 
fibrils and which are characterized by interruptions 
in the GIy-X-Y repeat sequences. Type IV col- 
lagen, the best characterized type of this group, is 
composed of two chains, eel(IV) and o~2(IV) [2]. 
The carboxyl-terminal end of these chains is a 
globular structure termed NC-1, the rest being a 
discontinuous collagen sequence. The amino acid 
sequence of the NC-1 domains of both chains from 
man [3-5] and mouse [6-8] sources has been 
reported. About 70°7o f the amino acid sequence 
for the collagenous part of the human [3,9,10] and 
about 30°7o of the mouse [5,11,12] eel(IV) chain 
have been reported and about 35°7o f the mouse 
oe2(IV) chain [13,14]. Sequence data have 
demonstrated that the NC-1 domains of the mam- 
malian o'I(IV) and a,2(IV) chains share considerable 
interchain homology (63°7o) in the amino acid se- 
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quence [5]. A type IV collagen-like crchain has also 
been identified in Drosophila [15,16]. The se- 
quence of the NC-1 domain of this chain is 59% 
identical with the Crl(IV) and a2(IV) chains from 
both man and mouse [15,16]. In contrast, the 
overall homology between the amino acid sequence 
of the triple-helical domains of the two vertebrate 
type IV oe chains is much lower or only about 22% 
when the invariant glycyl residues are excluded [5]. 
Similarly, the homology between the Drosophila o~ 
chain and the mammalian aq(IV) and oe2(IV) chains 
is only 10 and 8.5°70, respectively [15,16]. 
The division of collagen types into three groups 
appears to hold also remarkably well when con- 
sidering the gene structure of respective collagen 
types. Thus, the exon structure of the genes for the 
oe chains of the fibrillar collagens of types I - I I I  
and V is extremely homologous from avians to 
man [17-21]. Most of the Gly-X-Y coding exons 
have lengths of 54, 108 or 162 bp, the rest being 45 
or 99 bp long. These observations have led to the 
hypothesis that the triple-helical domain of col- 
lagen may have evolved by tandem duplication of 
a 54 bp long ancestor element [17,19]. Studies on 
the genes for type IV collagen have shown the 
absence of 54 bp exons [22-26] which 
demonstrates that the genes for fibrillar and non- 
fibrillar collagens have diverged extensively if they 
derive from a common ancestor gene. The close 
relationship between the o~l(IV) and ce2(IV) genes is 
further signified by the finding that their gene loci 
are in the same region at the distal part of the long 
arm of chromosome 13 [27,28]. The genes for the 
other collagens of this group, types VI-VI I I ,  have 
not yet been isolated. The gene for type IX col- 
lagen of group 3 has features in common with both 
the genes for group 1 collagens and the genes for 
type IV collagen. These features include 54 bp ex- 
ons coding for GIy-X-Y repeats but also several 
other sizes and furthermore many glycine codons 
are split at the intron-exon junctions as found in 
the type IV collagen genes [29]. The gene for chick 
type X collagen, a short chain collagen found in 
hypertrophic artilage, is very different in struc- 
ture from other collagen genes because it does not 
contain intervening sequences [30]. 
Here, we describe the exon-intron structure of 
the 3 '-end of the human oe2(IV) gene and compare 
it with the human C~l(IV) gene and the type IV col- 
lagen gene from Drosophila. 
2. MATERIALS AND METHODS 
2.1. Materials 
Restriction endonucleases, T4DNA ligase, DNA 
polymerase I (Klenow fragment), nick-translation 
kit and proteinase K were purchased from Boehr- 
inger Mannheim (FRG) and used according to the 
suppliers' recommendations. 32p-labeled dCTP 
and ass-labeled dATP were provided by New 
England Nuclear (Boston, MA). The cloning vec- 
tors, M13 mpl8, M13 mpl9 and pUC18, were sup- 
plied by Boehringer Mannheim and nitrocellulose 
filters were obtained from Schleicher and Schuell. 
Site-specific oligonucleotide primers were syn- 
thesized with a DNA synthesizer (Applied 
Biosystems). 
2.2. DNA clones 
cDNA clones (HD-3, HD-4) used for the screen- 
ing of the genomic library code for about 30%o of 
the 3 '-end of the mRNA and have been described 
previously [5]. The human genomic AluI/HaelII 
library in A Charon 4A was a kind gift from Dr 
Eric Fritsch. The genomic library was infected to 
E. coli LE392 and plated. Replicate filters were 
made and screened with the nick-translated probes 
according to standard procedures [31]. One 
positive clone was isolated and mapped by restric- 
tion endonuclease analysis and Southern blotting. 
2.3. DNA sequencing 
The genomic clone studied here was digested 
with suitable restriction endonucleases and the 
fragments were subcloned into the M13 vector [32] 
for sequencing. The M13 clones were sequenced 
using the Sanger dideoxynucleotide method [33] 
either with the 'universal primer' or site-specific 
oligonucleotide primers. 
3. RESULTS 
3.1. Identification of or2(lV) genome clones 
Our recently characterized human oe2(IV) cDNA 
clones, HD-3 and HD-4, that code for 2.2 kb of 
the nucleotide sequence of the 3'-end of the 
mRNA [5], were used to screen 300000 colonies of 
the human genomic A phage library. One positive 
clone, termed G-2.1, containing 12200bp of 
genomic DNA was purified and characterized by 
restriction endonuclease mapping and Southern 
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hybridization using subcloned fragments of the 
cDNA clones and genomic subclones as probes 
(fig.l). Several appropriate genomic fragments, 
isolated using XbaI which has suitable restriction 
sites in the cDNA clones and PstI, BamHI and 
EcoRI (see fig.l) were subcloned into M13 [32] for 
sequencing with the Sanger procedure [33]. The 
sizes of the exons and determination of their ap- 
proximate location in the gene could be obtained 
directly by nucleotide sequencing, either using the 
universal primer or synthetic oligonucleotides that 
were designed based on the human sequence 
known from the cDNA. As can be seen in fig. l, the 
six most 3' exons encoding about 25070 of the 
mRNA are contained in about 10 kb of genomic 
DNA. This indicates that the gene is very large, as 
is the case for the human aq(IV) gene [22,23]. 
3.2. Exon structure 
The sequencing analysis established several 
distinct features of the aE(IV) gene (fig.l). Exon 1 
from the 3'-end is 1088 bp long and codes for the 
entire 3'-untranslated region (833 bp) and 255 bp 
coding for a part of the NC-1 domain. Exon 2 is 
287 bp long and exon 3 is a fusion exon containing 
139 bp coding for the NC-1 domain and 53 bp 
coding for the collagenous domain. Exons 4 
(117 bp), 5 (147 bp) and 6 (99 bp) encode the 
carboxyl-terminal end of the collagenous domain. 
Because of the close structural relationship be- 
tween the two type IV collagen polypeptide chains 
it was of interest o compare the structure of the 
erE(IV) gene studied here with the comparable 
region of the Ot'l(IV) gene we have previously 
described [22,23]. This comparison (fig.2) 
demonstrates that although highly related, the two 
genes have indeed developed ifferently. First of 
all, in the a,2(IV) gene the 3'-untranslated region 
and the NC-1 domain are coded for by only three 
exons of which exon 3 is a junction exon contain- 
ing coding sequences also for a part of the col- 
lagenous domain. In contrast, the NC-1 domain of 
the oil(IV) gene is encoded by five exons. This dif- 
ference in structure between the genes is surprising 
because as much as 63°70 of the amino acids of the 
NC-1 domains of the two chains in both man [3,5] 
and mouse [6-8] are identical. The two genes 
could therefore be expected to have similar struc- 
ture. Alignment of the exon sequences of the 
eel(IV) and a'E(IV) genes showed, however, that 
after all there is a considerable intergene relation- 
ship (fig.2). Thus, the coding sequences at the 
boundaries of exons 1 and 2 in the teE(IV) gene and 
exons 2 and 3 in the o'I(IV) gene as well as their 
[ ]  G ly -X -Y -cod lng  
[ ]  NC-1 domain  
[ ]  3' unt rans la ted  
99 147 117 ~ I / 192 287 255 + 833 
360 200 1900 1300 3800 
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I I  I I I I I I I I 
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Fig. 1. Restriction map, exon and intron sizes and locations in the cez(IV) collagen coding G-2.1 genomic lone. Coding 
sequences are indicated by boxes. Sizes of exons (bp) are shown above the exons and the approximate sizes of introns 
are shown above the intron representing lines. Restriction endonuclease cleavage sites of BamHI (B), HindIII (H), KpnI 
(K), PstI (P) and XbaI (X) in the G-2.1 clone are illustrated below the scheme of the genomic lone. 
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Fig.2. Comparison of the exon structure at the 3' -ends of the human genes for type IV collagen c~ and or2 chains. Exons 
are indicated by boxes and introns by the interconnecting lines. Exon (E) numbering from the 3'-end is shown. 
Interrupted vertical ines illustrate intron positions that are identical in both genes. Locations of the other intervening 
sequences do not match. An intron location in the type IV collagen gene of Drosophila [16] that is common with a 
mammalian location is also illustrated below the mammalian genes. 
deduced amino acid sequence matched (fig.2). 
Similarly, the coding sequences at the boundaries 
of exons 2 and 3 of the o~2(IV) gene and exons 4 and 
5 of the oq(IV) gene matched (figs 2,3). The dif- 
ferences involve two extra introns and a longer 
3 '-untranslated region in the cr](IV) gene as well as 
nucleotide substitutions and presumably deletions 
resulting in replacements and loss of amino acids 
so that the NC-1 domain of the cr](IV) chain has 
two amino acids more than that of the o~2(IV) chain 
[5]. The total divergence between the NC-1 do- 
mains of the two human chains based on pairwise 
comparison is 35%. One intron position has been 
identified in the NC-1 domain coding region of the 
Drosophila type IV collagen gene [16] and in- 
terestingly, it matches perfectly with a location 
conserved between the human O~l(IV) and cr2(IV) 
genes (fig.2). 
Another peculiar feature when comparing the 
cry(IV) and ce2(IV) genes is the structure of the ex- 
ons coding for the GIy-X-Y repeats, since the sizes 
of the exons compared here are all different (figs 
1-3). The junction exon of the oe2(IV) gene has 53 
nucleotides coding for such a Gly-X-Y repeat 
whereas the junction exon of the O~l(IV) gene has 
71 bp. The next three 5'-exons of the o~2(IV) gene 
have sizes of 117, 147 and 99 bp whereas com- 
parable exons in the a,l(IV) gene are 99, 129, 72 
and 73 bp, respectively. Alignment of the Gly-X-Y 
repeat coding sequences of the genes established, 
however, structural similarities between the two 
genes. When calculated upstream from the beginn- 
ing of the GIy-X-Y coding sequence the boundaries 
of exons 4 and 5 in the cr2(IV) gene and exons 6 and 
7 from the o:](IV) gene match (figs 2,3). However, 
as depicted in figs 2 and 3 the boundaries between 
exons 3 and 4 in the o~2(IV) gene and exons 5 and 
6 in the o~l(IV) gene do not match nor do the boun- 
E 10 E9  E8  E7  E6  E5  E4 
I I I  I I  I I  IN I 
I I~1  I I I II i l l  l, 
281 ~ 54  i 129  =18 i 
, ' ,H  II ,i 
i i 45  -~18i 01 99  =l 53  i 
I I  I I  I I  I I  I 
E7 E6  E5  E4  E3  E2 
~l(IV) 
~2( IV)  
Fig.3. Illustration of common and mismatching exon-intron junctions in the 3'-end of the GIy-X-Y coding region of 
the human eel(IV) and ce2(IV) genes. The reference point (0 bp) is the junction of the Gly-X-Y coding (dark box) and 
NC-1 domain (cross-hatched) coding sequences ( ee [5]). The positions of introns 4 and 6 in the oel(IV) gene and introns 
2 and 4 in the ce2(IV) gene, respectively, match perfectly. The lengths (bp) of mismatches between exons are shown. 
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daries of exons 5 and 6 from the o'2(IV) gene on the 
one hand and those of exons 7 and 8 from the 
eel(IV) on the other. In both cases there is a 
mismatch of 18 bp (fig.3). Similarly, there is a 
45 bp mismatch at the intron location between ex- 
ons 6 and 7 in the cez(IV) gene and exons 8 and 9 
in the eel(IV) gene (fig.3). On the other hand, the 
positions of introns between exons 6 and 7 in the 
cez(IV) gene and exons 9 and 10 in the crl(IV) gene 
have a 28 bp mismatch. Accordingly, although 
partially similar in structure, there has not been a 
strong evolutionary pressure to maintain the same 
sizes of GIy-X-Y coding exons in the two related 
type IV collagen genes. This is in clear con- 
tradistinction to the genes for the group 1 collagen 
genes, aq(I), a,2(I), crl(II) and cel(III), that all have 
exactly the same exon size distribution of GIy-X-Y 
coding exons [17-20]. 
3.3. Sequences of exon-intron junctions 
Analysis of the exon-intron junctions around ex- 
ons 3-6 showed that all the Gly-X-Y exons studied 
here start with the second base of the codon for 
glycine (rigA). Exon 2 that encodes equences of 
the NC-1 domain also starts with the second base 
of a codon for glycine. In contrast, exon 1 starts 
with a complete codon CAC for histidine. The 
presence of split glycine codons appears to be 
typical for the type IV collagen genes, since present 
data [22,24,25] show that out of 13 exons reported 
to start with a codon for glycine, 10 start with the 
second base of the codon. Split codons for glycine 
are not found in the genes for fibrillar collagens 
(see [17-20]) which further demonstrates the 
evolutionary distance between the genes for type 
IV collagen and genes for fibrillar collagens. 
4. DISCUSSION 
The present results clearly established that the 
genes for the human eel(IV) and cez(IV) chains are 
5 ~ 31  
EXON 6 tgttgcag GG CCC AGG GGT . . . . . .  GGA TTC CCT G gtaagtga 
99 bp (Gly) Pro Arg Gly Gly Phe Pro 
EXON 5 ccttccag GT GCC CCC GGG . . . . . .  GGA GAA CCA G gtagagtg 
147 bp (Gly) Ala Pro Gly Gly Glu Pro 
EXON 4 gcttgcag GT TTT CGT GGG . . . . . .  GGC CAA GAA G gtgagtga 
117 bp (Gly) Phe Arg Gly Gly Gln Glu 
EXON 3 ctgcag GT GCA CCA GGC . . . . . .  CAG GAC CTG G gtaggtac 
192 bp (Gly) Ala Pro Gly Gln Asp Leu 
EXON 2 ttccacag GG CTG GCG GGC . . . . . .  TTC CTC ATG gtatgtgg 
287 bp (Gly) Leu Ala Gly Phe Leu Met 
EXON I ctgtacag CAC ACG GCG 
1088 bp His Thr Ala 
(255+833) 
,,. ATT TTT AAA ccccgagt 
Fig.4. Nucleotide sequence at the intron-exon boundaries of exons 1-6 of the human ce2(IV) gene (see figs 1-3). Lower- 
case letters are intron nucleotide sequences. The derived amino acid sequence is shown below exon coding sequences. 
The broken line flanking the 5'-end of exon 3 illustrates incompleted sequence. 
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closely related. This is in agreement with the exten- 
sive homology of primary structure reported for 
the NC-1 domain of the respective polypeptide 
chains [3-8]. It is also apparent that the difference 
in gene structure between the crl(IV) gene on the 
one hand and genes for group 1 collagens on the 
other [22-24] also holds for the a,2(IV) gene. 
However, the results of this study also demonstrate 
that the two type IV collagen genes differ quite 
substantially. In fact, the differences in the struc- 
ture of the two related type IV collagen genes are 
more prominent than those between the genes for 
the different types of group 1 collagens (types 
I - I I I ,  V). These observations raise questions about 
the evolution of the type IV collagen genes, of col- 
lagen genes in general but in particular why so 
much more divergence has been tolerated in the 
development of type IV collagen genes that code 
for homologous polypeptides present in the same 
molecule as opposed to the genes for group 1 col- 
lagens whose gene structure is stringently con- 
served. 
As described above, the region of the type IV 
collagen cr chain genes studied here contained nine 
exons coding for aq(IV) chain sequences but only 
six exons coding for the corresponding region of 
the c~2(IV) chain. Another striking finding was that 
three intron locations are precisely conserved be- 
tween the two mammalian genes, three intron loca- 
tions in the collagen coding region mismatch and 
two introns are completely lacking from the NC-1 
domain coding region of the cr2(IV) gene (figs 2,3). 
Interestingly, one of the two common intron loca- 
tions in the NC-1 domain coding region of the 
mammalian genes is exactly conserved in a type IV 
collagen gene of Drosophila ([16] fig.2). As yet it 
is not known whether the other common intron 
locations of the eel(IV) and oL2(IV) genes are con- 
served in Drosophila. As far as age is concerned, 
it is apparent that the type IV collagen gene must 
be more than 700 million years old, since it was 
present prior to the branchpoint of insects and 
vertebrates [34]. The present findings also indicate 
that the mammalian aq(IV) and ce2(IV) genes have 
developed from the ancestor gene through a gene 
duplication followed by an evolutionary process. 
Whether the gene duplication occurred before or 
after the radiation of insects and vertebrates is not 
completely sure. The finding of only one type IV 
collagen chain in Drosophila [15] indicates, 
however, that the duplication took place after the 
branching of vertebrates. 
The presence of common and uncommon intron 
locations in the mammalian and Drosophila genes 
shows that the evolutionary process of individual 
genes has involved either both selective and ran- 
dom loss of introns or alternatively both deletions 
and insertions of intron sequences. According to 
one hypothesis [35,36], selective loss of introns can 
explain cases where intron positions are not con- 
served between members of several multigene 
families [37-41]. If this hypothesis were solely to 
explain the evolutionary process of type IV col- 
lagen genes, the ancestor gene would have had at 
least five exons coding for the NC-1 domain and 
3'-untranslated region still present in the eel(IV) 
gene but also two 18 bp, one 28 bp, one 45 bp and 
one 54 bp exon coding for collagenous domains 
that have later been differentially fused as il- 
lustrated in fig.5. The presence of such exons in the 
ancestor gene would be necessary to explain the 
generation of the randomly formed mismatching 
introns because their position differences are too 
large to be accounted for by 'intron sliding' [42]. 
According to this hypothesis introns 6, 8 and 10 in 
the ancestor gene (fig.5) must have been deleted 
from the cr2(IV) gene and introns 5, 9 and 11 from 
the o~(IV) gene after the duplication of the 
ancestor gene since their loss was 'random'. The 
random loss of these introns also suggests that they 
are not functionally important. In contrast, intron 
2 in the ancestor gene could possibly contain some 
important regulatory elements because there may 
have been a selective pressure to maintain this in- 
tervening sequence. For example, a functional 
enhancer sequence has been found in the first 5' 
intron of the human ce2(I) gene (De Wet and De 
Crombrugghe, personal communication). 
Another hypothesis that could explain the 
divergent evolution of the type IV collagen genes 
states that common features of related genes repre- 
sent the structure of an ancestor gene when it was 
first duplicated and that introns could since then 
have been inserted randomly into the gene. Such a 
pattern has recently been proposed for the 
fibrinogen gene [43]. This hypothesis cannot be re- 
jected in the case of the mismatched introns in the 
o~(IV) and ce2(IV) genes. Actually, it has been 
shown that at least in the fl-globin gene exons 
smaller than 24 or 14 bp are spliced inefficiently, 
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Fig.5. Potential evolutionary process of the 3'-end of the human eel(IV) and oe2(IV) collagen gene after the duplication 
of a common ancestor gene. According to the hypothesis of Gilbert and others [36,37], differential loss of introns from 
a multi-intron ancestor gene can explain cases where intron positions are not always conserved between related genes. 
This hypothesis suggests that the part of the duplicated ancestor gene examined here had at least 11 introns. Only three 
of those, possibly functionally important, introns have been conserved whereas ome of the other introns were lost from 
the a~](IV) gene and others from the ot2(IV) gene. 
if at all [44]. This finding cannot be generalized, 
however, as an 11 bp long exon containing a part 
of the sequence coding for the signal peptide 
cleavage site has been identified in the chicken 
procr2(I) collagen gene [45]. The variability in exon 
sizes and also the locations of introns in the parts 
of the Oel(IV) and o'2(IV) genes that code for the 
Gly-X-Y repeats could also, at least partially, have 
developed through recombinational rrangements 
after an ancient common ancestor was duplicated. 
The presence of conserved sequence lements uch 
as those coding for the Gly-X-Y triplets should 
favour such recombination [46]. The generation of 
45 and 99 bp exons in the group 1 collagen genes 
may have occurred through unequal crossing-over 
between two 54 bp exons and the formation of 108 
and 162 bp exons by recombination between the 
gene and a cDNA intermediate [19,46]. The occur- 
rence of this kind of rearrangements cannot be ex- 
cluded for the type IV collagen genes. The exons in 
the hypothetical common ancestor or(IV) collagen 
gene depicted in fig.5 contain 45, 54 and 99 bp 
long exons but it is difficult to envisage how the 
hypothesis of recombination of 54 bp primordial 
unit exons can be applied to explain the develop- 
ment of the variable sizes of exons in the type IV 
collagen genes. Rather, it appears that such recom- 
bination processes have mainly involved unequal 
crossing-over of single GIy-X-Y coding units of 
9 bp in some cases with imperfections that have led 
to the formation of the interruptions typical for 
type IV collagen, and whose presence is tolerated 
in this collagen type. 
The experimental data presented here provide 
further evidence that type IV collagen genes belong 
to a distinct class of collagen genes that have 
followed a different evolutionary pathway from 
that of the genes for interstitial collagens of group 
1. The genes for group 1 collagens tudied thus far 
have a highly conserved pattern of exon sizes (see 
[17-21]). All the genes have four exons coding for 
the carboxyl-terminal propeptides and six exons 
coding for the noncollagenous amino-terminal end 
of the cr chains. Furthermore, the size distribution 
of exons coding for the triple-helical domain ~s 
identical with one exception [191. This highly con- 
served distribution of exon sizes is very different 
from the diverged size pattern of exons in the type 
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IV collagen genes. This fact raises the question as 
to why such an evolutionary drift has been 
tolerated in the type IV collagen genes but not in 
the genes for group 1 collagens. One explanation 
for this could lie in the fact that the formation of 
collagen fibrils requires the lateral alignment of 
collagen molecules of an optimal length and this 
would not allow a drift in gene structure leading to 
ce chains of variable length [19]. In contrast, an ex- 
actly equal length of collagen molecules may not 
be a prerequisite for the formation of type iv  col- 
lagen networks, so that there has not been a severe 
functional constraint o maintain exact lengths of 
the discontinuous collagenous domain. Still, the 
fact that there is a conservation of sites of interrup- 
tions in the triple helix [5] indicates that the evolu- 
tionary changes of exons have not happened 
completely at random. On the other hand, there 
has clearly been evolutionary pressure to maintain 
the primary structure of the NC-1 domain of the 
type IV collagen ce chains from Drosophila to man, 
probably because a certain structure of this do- 
main is required for the proper assembly of the 
molecules as well as intermolecular crosslinking. 
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